These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

162 related items for PubMed ID: 19997745

  • 21. Ocular Manifestations in Late Onset Behçet's Disease.
    Saadouli D, Mansour KB, Yahyaoui S, Afrit NE, Lahmar A, Afrit AE.
    Curr Aging Sci; 2021; 14(1):56-61. PubMed ID: 31994475
    [Abstract] [Full Text] [Related]

  • 22. A double-masked, randomized study to investigate the safety and efficacy of daclizumab to treat the ocular complications related to Behçet's disease.
    Buggage RR, Levy-Clarke G, Sen HN, Ursea R, Srivastava SK, Suhler EB, Altemare C, Velez G, Ragheb J, Chan CC, Nussenblatt RB, Bamji AT, Sran P, Waldmann T, Thompson DJ.
    Ocul Immunol Inflamm; 2007; 15(2):63-70. PubMed ID: 17558830
    [Abstract] [Full Text] [Related]

  • 23. Rapid and Sustained Efficacy of Golimumab in the Treatment of Multirefractory Uveitis Associated with Behçet's Disease.
    Fabiani C, Sota J, Rigante D, Vitale A, Emmi G, Vannozzi L, Franceschini R, Bacherini D, Frediani B, Galeazzi M, Tosi GM, Cantarini L.
    Ocul Immunol Inflamm; 2019; 27(1):58-63. PubMed ID: 28981395
    [Abstract] [Full Text] [Related]

  • 24. Short-term chlorambucil for refractory uveitis in Behcet's disease.
    Mudun BA, Ergen A, Ipcioglu SU, Burumcek EY, Durlu Y, Arslan MO.
    Ocul Immunol Inflamm; 2001 Dec; 9(4):219-29. PubMed ID: 11935432
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. High dose methotrexate for ocular lesions of Behçet's disease. Preliminary short-term results.
    Davatchi F, Shahram F, Chams H, Jamshidi AR, Nadji A, Chams C, Akbarian M, Gharibdoost F.
    Adv Exp Med Biol; 2003 Dec; 528():579-84. PubMed ID: 12918769
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Long-term efficacy of early infliximab-induced remission for refractory uveoretinitis associated with Behçet's disease.
    Keino H, Watanabe T, Nakayama M, Komagata Y, Fukuoka K, Okada AA.
    Br J Ophthalmol; 2021 Nov; 105(11):1525-1533. PubMed ID: 32972915
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Visual outcomes and ocular morbidity of patients with uveitis referred to a tertiary center during first year of follow-up.
    Groen F, Ramdas W, de Hoog J, Vingerling JR, Rothova A.
    Eye (Lond); 2016 Mar; 30(3):473-80. PubMed ID: 26742865
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.